Related references
Note: Only part of the references are listed.AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer
Anna C. Beck et al.
MOLECULAR CANCER RESEARCH (2021)
Heterodimerization of TFAP2 pioneer factors drives epigenomic remodeling during neural crest specification
Megan Rothstein et al.
GENOME RESEARCH (2020)
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global trimethylation of H3K27
Hao Fu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer
Shira Yomtoubian et al.
CELL REPORTS (2020)
Cross-species analysis of enhancer logic using deep learning
Liesbeth Minnoye et al.
GENOME RESEARCH (2020)
An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
Valentina Perotti et al.
ONCOGENE (2019)
Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
Florian Rambow et al.
GENES & DEVELOPMENT (2019)
The adjuvant treatment revolution for high-risk melanoma patients
Francesco Spagnolo et al.
SEMINARS IN CANCER BIOLOGY (2019)
A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease
Qi Sun et al.
NATURE COMMUNICATIONS (2019)
Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancer
Hironobu Yamashita et al.
ONCOGENESIS (2019)
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Florian Rambow et al.
CELL (2018)
Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target
Jinfeng Cao et al.
JOURNAL OF PATHOLOGY (2018)
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
Alison Hirukawa et al.
NATURE COMMUNICATIONS (2018)
Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3 (vol 9, pg 752, 2017)
Yongxin Yu et al.
STEM CELL REPORTS (2018)
RGAAT: A Reference-based Genome Assembly and Annotation Tool for New Genomes and Upgrade of Known Genomes
Wanfei Liu et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2018)
Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients
Hongying Hao et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood
Julia Joung et al.
NATURE (2017)
TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF
Hannah E. Seberg et al.
PLOS GENETICS (2017)
NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF
Mitchell E. Fane et al.
EBIOMEDICINE (2017)
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E. Gershenwald et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane
Matthew L. Fisher et al.
MOLECULAR CARCINOGENESIS (2016)
An improved smaller biotin ligase for BioID proximity labeling
Dae In Kim et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling
Jian-Fang Chen et al.
ONCOTARGET (2016)
TAZ and YAP are frequently activated oncoproteins in sarcomas
Colleen A. Fullenkamp et al.
ONCOTARGET (2016)
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
Daniel Zingg et al.
NATURE COMMUNICATIONS (2015)
TFAP2A Regulates Nasopharyngeal Carcinoma Growth and Survival by Targeting HIF-1α Signaling Pathway
Dingbo Shi et al.
CANCER PREVENTION RESEARCH (2014)
EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis
Heather M. Moore et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Enhanced Efficiency of Human Pluripotent Stem Cell Genome Editing through Replacing TALENs with CRISPRs
Qiurong Ding et al.
CELL STEM CELL (2013)
Epigenomic Annotation of Enhancers Predicts Transcriptional Regulators of Human Neural Crest
Alvaro Rada-Iglesias et al.
CELL STEM CELL (2012)
EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/CDKN1A Expression
Tao Fan et al.
MOLECULAR CANCER RESEARCH (2011)
EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients
Zhi-Yue Rao et al.
CARCINOGENESIS (2010)
Identification of Primary Gene Targets of TFAP2C in Hormone Responsive Breast Carcinoma Cells
George W. Woodfield et al.
GENES CHROMOSOMES & CANCER (2010)
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Li-Ru He et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
E2F1 in Melanoma Progression and Metastasis
Vijay Alla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells
Elena Ezhkova et al.
CELL (2009)
Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response
Yong-Wei Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Expression of polycomb group protein EZH2 in nevi and melanoma
Jonathan B. McHugh et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo
Susan X. Jiang et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data -: A case study using E2F1
Victor X. Jin et al.
GENOME RESEARCH (2006)
Increased gene copy number of the transcription factor E2F1 in malignant melanoma
MA Nelson et al.
CANCER BIOLOGY & THERAPY (2006)
Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment
PM Kulesa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Automated quantitative analysis of activator protein-2α subcellular expression in melanoma tissue microarrays correlates with survival prediction
AJ Berger et al.
CANCER RESEARCH (2005)
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway et al.
NATURE (2005)
Neural crest survival and differentiation in zebrafish depends on mont blanc/tfap2a gene function
A Barrallo-Gimeno et al.
DEVELOPMENT (2004)
Differential regulation of expression of the mammalian DNA repair genes by growth stimulation
R Iwanaga et al.
ONCOGENE (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase
J Wells et al.
ONCOGENE (2003)
Tumor suppressor activity of AP2α mediated through a direct interaction with p53
LA McPherson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
